Author

C. Gerke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 3 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Halenius· 2 shared A. A. de Waard· 1 shared A. Barinov· 1 shared A. Derbise· 1 shared A. H. de Ru· 1 shared A. Jongkaewwattana· 1 shared A. Mulder· 1 shared A. Noirat· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Halenius

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning

C. Gerke, L. Bauersfeld, V. Oberhardt, C. Jürges, R. Spaapen, C. Mussolino, V. T. K. Le-Trilling, M. Trilling, L. Dölken, F. Erhard, M. Hofmann, H. Hengel, F. Momburg, A. Halenius

This study investigates how HCMV US10 protein regulates HLA-I genotype and surface expression, revealing its multimodal effects on different HLA-I allotypes.

bioRxiv · Jan 10, 2023Microbiology

An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa

B. Vesin, J. Lopez, A. Noirat, P. Authie, I. Fert, F. Le Chevalier, F. Moncoq, K. Nemirov, C. Blanc, C. Planchais, H. Mouquet, F. Guinet, D. Hardy, C. Gerke, F. Anna, , P. Charneau

This study shows an intranasal lentiviral booster enhances and broadens immune response to SARS-CoV-2 variants and improves waning mRNA vaccine immunity in the lungs.

bioRxiv · Jan 30, 2022 · PreprintImmunology

A measles-vectored COVID-19 vaccine induces long-term immunity and protection from SARS-CoV-2 challenge in mice

P. N. Frantz, A. Barinov, C. Ruffie, C. Combredet, V. Najburg, S. Teeravechyan, A. Jongkaewwattana, M. Prot, L. Conquet, X. Montagutelli, P. Fernandes, H. Strick-Marchand, J. Di Santo, E. Simon-Loriere, C. Gerke, F. Tangy

bioRxiv · Feb 17, 2021 · PreprintImmunology

PAKC: A novel Panel of HLA class I Antigen presentation machinery Knockout Cells from the same genetic origin

A. A. de Waard, T. Verkerk, M. L. M. Jongsma, K. Hoefakker, S. Sethumadhavan, C. Gerke, S. Bliss, G. M. C. Janssen, A. H. de Ru, F. H. J. Claas, A. Mulder, R. Tampe, P. A. van Veelen, A. Halenius, R. M. Spaapen

The paper generates a panel of APM knockout cell lines to study HLA class I antigen presentation and its role in immune responses.

bioRxiv · Jan 24, 2020Immunology

Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine

A. Derbise, C. Guillas, C. Gerke, E. Carniel, J. Pizarro Cerda, C. E. Demeure

This study evaluates subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis strain as an alternative to oral vaccination for plague protection in mice.

bioRxiv · Oct 30, 2019Immunology